Deferasirox associated with liver failure and death in a sickle cell anemia patient homozygous for the −1774delG polymorphism in the Abcc2 gene.

MLA

Braga, Caroline C. B., et al. “Deferasirox Associated with Liver Failure and Death in a Sickle Cell Anemia Patient Homozygous for the −1774delG Polymorphism in the Abcc2 Gene.” Clinical Case Reports, vol. 5, no. 8, Aug. 2017, pp. 1218–21. EBSCOhost, https://doi.org/10.1002/ccr3.1040.

APA

Braga, C. C. B., Benites, B. D., Albuquerque, D. M., Alvarez, M. C., Seva, P. T., Duarte, B. K. L., Costa, F. F., Gilli, S. C. O., & Saad, S. T. O. (2017). Deferasirox associated with liver failure and death in a sickle cell anemia patient homozygous for the −1774delG polymorphism in the Abcc2 gene. Clinical Case Reports, 5(8), 1218–1221. https://doi.org/10.1002/ccr3.1040

Chicago

Braga, Caroline C. B., Bruno Deltreggia Benites, Dulcineia M. Albuquerque, Marisa C. Alvarez, Pereira, Tiago Seva, Bruno K. L. Duarte, Fernando F. Costa, Simone C. O. Gilli, and Sara T. O. Saad. 2017. “Deferasirox Associated with Liver Failure and Death in a Sickle Cell Anemia Patient Homozygous for the −1774delG Polymorphism in the Abcc2 Gene.” Clinical Case Reports 5 (8): 1218–21. doi:10.1002/ccr3.1040.